Transcranial Doppler ultrasonography predicts cardiovascular events after TIA by Holzer, Katrin et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Medical Imaging
Open Access Research article
Transcranial Doppler ultrasonography predicts cardiovascular 
events after TIA
Katrin Holzer1, Suwad Sadikovic*1, Lorena Esposito1, Angelina Bockelbrink2, 
Dirk Sander3, Bernhard Hemmer1 and Holger Poppert1
Address: 1Department of Neurology, Klinikum rechts der Isar, Technische Universität, Munich, Germany, 2Institute for Social Medicine, 
Epidemiology, and Health Economics, Charité University Medical Centre, Berlin, Germany and 3Department of Neurology, Medical Park Hospital, 
Bischofswiesen, Germany
Email: Katrin Holzer - katrin.bruckmaier@gmx.de; Suwad Sadikovic* - sadikovic@lrz.tum.de; Lorena Esposito - lorenaesposito@web.de; 
Angelina Bockelbrink - angelina.bockelbrink@charite.de; Dirk Sander - d.sander@mac.com; Bernhard Hemmer - hemmer@lrz.tu-muenchen.de; 
Holger Poppert - poppert@neurovasc.de
* Corresponding author    
Abstract
Background: Transient ischemic attack (TIA) patients are at high vascular risk. We assessed the
value of extracranial (ECD) and transcranial (TCD) Doppler and duplex ultrasonography to predict
clinical outcome after TIA.
Methods: 176 consecutive TIA patients admitted to the Stroke Unit were recruited in the study.
All patients received diffusion-weighted imaging, standardized ECD and TCD. At a median follow-
up of 27 months, new vascular events were recorded.
Results:  22 (13.8%) patients experienced an ischemi c  s t r ok e  or  T I A ,  5  ( 3 . 1 % ) a m yo c a rd i a l
infarction or acute coronary syndrome, and 5 (3.1%) underwent arterial revascularization. ECD
revealed extracranial ≥ 50% stenosis or occlusions in 34 (19.3%) patients, TCD showed intracranial
stenosis in 15 (9.2%) and collateral flow patterns due to extracranial stenosis in 5 (3.1%) cases.
Multivariate analysis identified these abnormal ECD and TCD findings as predictors of new cerebral
ischemic events (ECD: hazard ratio (HR) 4.30, 95% confidence interval (CI) 1.75 to 10.57, P = 0.01;
TCD: HR 4.73, 95% CI 1.86 to 12.04, P = 0.01). Abnormal TCD findings were also predictive of
cardiovascular ischemic events (HR 18.51, 95% CI 3.49 to 98.24, P = 0.001).
Conclusion: TIA patients with abnormal TCD findings are at high risk to develop further cerebral
and cardiovascular ischemic events.
Background
After a transient ischemic attack (TIA), patients are at high
risk to develop further vascular events. The risk of stroke
within the first 90 days after TIA is 4% to 20%, with half
of the events occurring within the first 2 days [1-6]. Con-
sequently, the early risk of stroke after TIA is comparable
to, or even higher than, the short-term risk of myocardial
infarction (MI) and major cardiovascular complications
in patients presenting with chest pain [7]. Several clinical
characteristics such as advanced age [2,8-10], diabetes
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mellitus [2,9], hypertension [9,10], weakness [2,9,10],
speech impairment [2,9,10], prolonged symptom dura-
tion [2,8-10], evidence of acute ischemia on brain imag-
ing [3,6,11,12], extracranial or intracranial large-artery
occlusive disease [3,6,13-15], and cardioembolism [14],
have been reported to be independently associated with a
higher incidence of early subsequent stroke after TIA.
Recently a new scoring system for evaluating short-term
stroke risk after TIA (ABCD2 score) based on 5 clinical fac-
tors has been validated [9,16,17]. The predictive power of
the ABCD2 model seems to be partially explained by iden-
tification of those patients likely to have experienced a
true TIA [18].
Whereas the risk of stroke is highest in the first year after
TIA, ranging from 7% to 21% [1,5,8,19,20], and after-
wards declines to an annual rate of 2% to 6% over the first
4 to 5 years [19-21], the annual risk of coronary events
after TIA remains stable at about 2% to 3% for several
years [19,20]. On long-term follow-up, cardiovascular dis-
ease becomes the major cause of death after TIA [22]. The
10-year risk of vascular events in TIA patients is reported
to be 36% and the 10-year risk of death 34% respectively
[23]. Several studies have already demonstrated a high
prevalence of asymptomatic coronary artery disease
(CAD) in patients with TIA and mild ischemic stroke (IS),
ranging from 28% to 41% [24-26]. Routine screening tests
for CAD in all patients with cerebrovascular disease may
not be cost-effective, however. Healthcare professionals
currently are encouraged to optimize coronary risk evalu-
ation in patients with TIA and IS based on the individual
cardiovascular risk profile and the prevalence of carotid
artery disease [27].
In this study, we aimed to assess the value of extracranial
(ECD) and transcranial (TCD) Doppler and duplex ultra-
sonography to predict the occurrence of cerebrovascular
and cardiovascular events after TIA.
Methods
We identified 262 patients with possible cerebral TIA,
who had been consecutively admitted to the Stroke Unit
of the Department of Neurology, Technical University
Munich, within the first 72 hours after symptom onset
between May 2000 and July 2004. Diagnosis was made by
the attending neurologist before patient selection. TIA was
defined as an acute transient focal neurological deficit
caused by vascular disease, which completely reversed
within 24 hours [28]. Patients with amaurosis fugax were
not included in the study, as data suggest pathogenic and
prognostic differences between transient eye and brain
ischemic syndromes [29,30].
To be eligible, patients had to undergo cerebral magnetic
resonance imaging (MRI) including diffusion-weighted
imaging (DWI) sequences within 5 days after onset of
symptoms, which was the case in 225 patients. 49 patients
were excluded for the following reasons: competing differ-
ential diagnosis as assessed by the attending neurologist,
41 cases (migraine, 8 cases; epilepsy, 7 cases; functional
disorder, 5 cases; peripheral dizziness, 4 cases; syncope, 4
cases; hypertensive crisis, 4 patients; others, 9 cases);
malignancy requiring active treatment, 7 cases; concomi-
tant participation in a pharmaceutical trial; 1 case.
Informed consent was obtained of every patient.
Routine admission examinations involved evaluation of
medical history, physical examinations, blood analysis
including lipid and glucose metabolism, resting and 24-
hour electrocardiogram, 24-hour blood pressure measure-
ment, transthoracic echocardiography, ECD, TCD, and
cerebral MRI including DWI sequences. Symptom dura-
tion was systematically documented.
The following baseline clinical data were collected: age,
sex, symptom duration, presence of classic vascular risk
factors, and medical history of CAD, cardiac failure, and
peripheral artery disease (PAD) (Additional file 1). Hyper-
tension was defined as systolic blood pressure ≥ 140
mmHg, diastolic blood pressure ≥ 90 mmHg, or current
use of antihypertensive medication; diabetes mellitus as
fasting blood glucose ≥ 126 mg/dL or current use of anti-
diabetic agents; and hypercholesterolemia as total choles-
terol  ≥ 240 mg/dL or current use of lipid-lowering
medication. Nicotine abuse was defined as current or
former regular smoking. Atrial fibrillation was defined as
history of electrocardiographically documented intermit-
tent or persistent atrial fibrillation. TIA was allocated to
the carotid or vertebrobasilar territory by an experienced
neurologist based on clinical symptoms and MRI.
ECD and TCD were performed within a maximum of 3
days after admission using multi-range doppler (DWL
Multi-Dop; Compumedics Germany GmbH) and duplex
ultrasound devices (Siemens Sonoline Elegra; Siemens
AG).
ECD findings were classified as follows: normal (1), if
there was no evidence of plaques both in the cervical
internal carotid (cICA) and cervical vertebral arteries
(cVA); atherosclerosis without stenosis (2), if cICA or cVA
showed at least one plaque with < 50% stenosis of the cor-
responding vessel; stenosis (3), if cICA or cVA showed at
least one ≥ 50% stenosis or an occlusion. ECD classifica-
tion did not distinguish between symptomatic and
asymptomatic vessel disease.
TCD findings were classified as follows: normal (1), if
TCD detected no pathological findings or only minor
side-to-side differences of the distal internal carotidBMC Medical Imaging 2009, 9:13 http://www.biomedcentral.com/1471-2342/9/13
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(dICA), middle cerebral (MCA), posterior cerebral (PCA),
or intracranial vertebrobasilar (VBA) artery; reactive col-
lateral flow patterns (2), if TCD demonstrated collateral
blood flow through the circle of Willis secondary to
extracranial lesions; stenosis (3), if dICA, MCA, PCA, or
VBA showed at least one intracranial stenosis or an occlu-
sion. TCD diagnosis of intracranial stenosis was defined
by increased peak flow velocities (≥ 155 cm/s for dICA
and MCA; ≥ 100 cm/s for PCA and VBA) with side-to-side
differences > 20% and disturbed flow patterns [31,32].
PCA signal was identified by posterior angulation of the
probe during transtemporal insonation using an insona-
tion depth of 60 to 70 mm. For identification of VBA we
applied an insonation depth of 6079 mm (intracranial
vertebral arteries) and 80110 mm (basilar artery) during
suboccipital insonation. TCD classification did not distin-
guish between symptomatic and asymptomatic vessel dis-
ease.
Cerebral MRI was performed within a maximum of 5 days
after symptom onset in all patients. No patient developed
a follow-up cerebrovascular event before MRI.
All MRI scans were obtained using a 1.5-Tesla scanner
(Magnetom Symphony; Siemens AG). Imaging protocol
included axial T1-weighted (TR/TE 654/14 ms), T2-
weighted (TR/TE 3305/132 ms), and DWI sequences (TR/
TE 4006/83 ms, slice thickness 4 to 6 mm, interslice gap
1.5 mm, pixel matrix 128 × 128, field of view 220 × 220
mm, pixel size 1.72 × 1.72 mm, gradient strength 30 mT/
m, b-values = 0, 500, 1000 s/mm2), and in doubtful cases
additionally a sagittal or coronal DWI sequence. ADC
maps were constructed by linear least-squares fit on a
pixel-by-pixel basis after averaging the direction-depend-
ent DWI values.
DWI scans were considered positive for ischemia if both a
hyperintensity on the isotropic b = 1000 scan and a corre-
sponding hypointensity on the ADC map were detectable.
At a median follow-up of 27 months (minimum 4
months, maximum 64 months) all 176 patients were con-
tacted via telephone or mail by an experienced neurolo-
gist blinded to the patients' ultrasonographic findings. A
semi-structered interview was used to assess new cerebral
ischemic or other vascular events. If the interview pro-
vided insufficient data or any indication of follow-up
events, data were completed by contacting relatives,
attending physicians and/or hospitals. Our main points of
interest were cerebral ischemic events (ischemic stroke or
TIA), cardiovascular ischemic events (MI or acute coro-
nary syndrome (ACS), surgical or endovascular revascu-
larization procedures in CAD or PAD), and death of
vascular or unknown cause. Other vascular events and
death of nonvascular cause also were documented. If a
patient reported symptoms possibly consistent with a fol-
low-up event but did not seek medical aid or had compet-
ing differential diagnoses as reported by the attending
physician, this information was documented but not con-
sidered as an outcome event.
All analyses were performed with the SPSS statistical pack-
age version 15.0. Univariate Cox regression analysis was
used to detect variables associated with the occurrence of
endpoints. Cox proportional hazards multivariate analy-
sis adjusted for age and sex was applied to identify inde-
pendent predictors of cerebral ischemic events,
cardiovascular ischemic events, and the combined end-
point of cerebral ischemic events, cardiac ischemic events,
and death of vascular or unknown cause. P < 0.05 was
considered as significant. Percentage values are relative to
the patent subset with complete data record.
The research protocol was approved by the local ethical
committee.
Results
A total of 176 Caucasian TIA patients were included in the
study. Table 1 shows the baseline characteristics of the
study population. Medical history revealed former IS, TIA,
or amaurosis fugax in 40 (23.1%) patients. 9 (5.1%)
patients reported a TIA during the last month before
admission.
Mean symptom duration was 4.7 ± 7.1 hours, with 65
(37.6%) patients having symptoms lasting < 1 hour. TIA
was allocated to the carotid territory in 125 (71.0%)
patients and to the vertebrobasilar territory in 42 (23.9%)
patients; 9 further cases (5.1%) could not be classified on
the basis of symptoms and MRI. DWI showed signal
intensity changes suggestive of cerebral ischemia in 49
(28.3%) patients.
Table 1: Baseline characteristics of study population (n = 176)
Age (y)* 63.3 ± 14,5
Sex, female (n) 67 (38.1%)
Hypertension (n) 127 (72.2%)
Diabetes mellitus (n) 28 (15.9%)
Hypercholesterolemia (n) 84 (48.6%)
Body mass index* 25.8 ± 3.9
Nicotine abuse (n) 80 (45.5%)
Atrial fibrillation (n) 24 (13.6%)
Coronary artery disease (n) 35 (19.9%)
Cardiac failure (n) 11 (6.4%)
Peripheral artery disease (n) 13 (7.4%)
DWI abnormality (n) 49 (28.3%)
Duration (h)* 4.7 ± 7.1
Duration ≥ 1 h and/or DWI abnormality (n) 123 (72.4%)
Vertebrobasilar TIA (n) 42 (23.9%)
ECD: stenoocclusion (n) 34 (19.3%)
TCD: abnormal (n) 20 (12.3%)
*Mean ± standard deviation.BMC Medical Imaging 2009, 9:13 http://www.biomedcentral.com/1471-2342/9/13
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ECD detected plaques without stenosis in 84 (47.7%)
patients and ≥ 50% stenosis or occlusions in 34 (19.3%)
patients. 24 (13.6%) patients showed a stenosis of the
cICA, 3 (1.7%) an occlusion of the cICA, 4 (2.3%) a sten-
osis of the cVA, 2 (1.1%) an occlusion of the cVA, and 1
(0.6%) stenosis or occlusions of both the cICA and cVA. 6
(3.4%) patients had a high-grade cICA stenosis of ≥ 80%.
5 of these patients underwent subsequent carotid endar-
terectomy and 1 patient stent-supported angioplasty.
TCD detected intracranial stenosis in 15 (9.2%) patients
and reactive collateral blood flow due to stenosis of the
cICA in 5 (3.1%) patients. 9 (5.1%) patients showed a ste-
nosis of the dICA or MCA, 1 (0.6%) an occlusion of the
dICA or MCA, 3 (1.7%) a stenosis of the PCA, 1 (0.6%) a
stenosis of the VBA, and 1 (0.6%) stenosis of both the
cICA or MCA and PCA. In 13 (7.4%) patients, TCD could
not be applied because of inadequate temporal bone win-
dows.
Tandem lesions of both the cICA and ipsilateral dICA or
MCA were detectable in 3 (1.8%) patients.
Follow-up endpoints
Follow-up data was available of 173 (98.3%) patients. 9
(5.7%) patients suffered an IS and 14 (8.8%) a further
TIA; 9 (5.7%) more patients reported symptoms possibly
consistent with cerebral ischemia but did not seek medical
aid or had competing differential diagnoses as reported by
the attending physician. In 7 of 14 patients with follow-up
TIA, a new MRI was performed, which detected an acute
ischemic lesion in only 1 patient.
3 (1.8%) patients experienced a MI and 2 (1.2%) an ACS
during follow-up; a further 4 (2.4%) patients underwent
surgical or endovascular revascularization in CAD, and 1
(0.6%) patient had bypass surgery in PAD. Additionally,
4 (2.4%) patients suffered from their first-ever angina pec-
toris attack, and 10 (6.0%) patients experienced other vas-
cular events (cardiac syncope, 4 cases; pacemaker
implantation, 2 cases; aortic valve surgery, 1 case; Wolff-
Parkinson-White syndrome, 1 case; deep vein thrombosis,
1 case; pulmonary embolism, 1 case). 15 (8.5%) patients
died due to the following reasons: cardiac failure, 3
(1.7%) cases; malignancy, 3 (1.7%) cases; pneumonia, 2
(1.1%) cases; unknown cause, 7 (4.0%) cases.
Figure 1 shows the graded risk of new cerebral ischemic
events and cardiovascular ischemic events based on ECD
and TCD findings.
Predictors of new cerebral ischemic events
In univariate analysis (Table 2), detection of stenosis by
ECD (hazard ratio (HR) 4.39, 95% CI 1.93 to 9.99, P <
0.01), evidence of reactive collateral flow patterns or
intracranial stenosis by TCD (HR 4.99, 95% CI 1.97 to
12.62, P < 0.01), and PAD (HR 7.64, 95% CI 2.96 to
19.71, P < 0.01) were significantly associated with follow-
up IS or TIA. A trend that did not reach significance was
also found for the parameters prolonged symptom dura-
tion (HR 1.04, 95% CI 1.00 to 1.10, P = 0.07), advanced
age (HR 1.03, 95% CI 0.99 to 1.06, P = 0.11), and cardiac
failure (HR 3.39, 95% CI 1.00 to 11.55, P = 0.05). Evi-
dence of acute ischemia on DWI had no significant effect
in our study. Cox proportional hazards multivariate anal-
Graded risk of new vascular events based on ECD and TCD findings Figure 1
Graded risk of new vascular events based on ECD and TCD findings.
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ysis (Table 3) confirmed pathological ECD and TCD find-
ings (ECD: HR 4.30, 95% CI 1.75 to 10.57, P = 0.01; TCD:
HR 4.73, 95% CI 1.86 to 12.04, P = 0.01) to be predictors
of new cerebral ischemic events.
Predictors of new cardiovascular ischemic events
Detection of extracranial stenosis by ECD (HR 3.73, 95%
CI 1.05 to 13.31, P = 0.04), proof of reactive collateral
flow patterns or intracranial stenosis by TCD (HR 9.62,
95% CI 2.46 to 37.68, P < 0.01), and diabetes mellitus
(HR 5.00, 95% CI 1.40 to 17.86, P = 0.01) were signifi-
cantly associated with the occurrence of MI, ACS, or revas-
cularization procedures in univariate analysis (Table 2).
However, whereas abnormal TCD findings (HR 18.51,
95% CI 3.49 to 98.24, P = 0.001) proved to predict cardi-
ovascular ischemic events in multivariate analysis (Table
3), pathological ECD findings (HR 2.93, 95% CI 0.77 to
11.17, P = 0.116) failed to reach significance in multivar-
iate analysis.
Predictors of the combined endpoint of cerebral ischemic 
events, cardiac ischemic events, and death of vascular or 
unknown cause
In univariate analysis, detection of extracranial stenosis by
ECD (HR 4.18, 95% CI 2.04 to 8.59, P < 0.01), evidence
of reactive collateral flow patterns or intracranial stenosis
by TCD (HR 5.13, 95% CI 2.26 to 11.67, P  < 0.01),
advanced age (HR 1.04, 95% CI 1.01 to 1.07, P < 0.01),
PAD (HR 7.42, 95% CI 3.25 to 16.94, P < 0.01), and car-
diac failure (HR 3.97, 95% CI 1.51 to 10.45, P < 0.01)
were significantly associated with the combined endpoint
of IS or TIA, MI or ACS, and death of vascular or unknown
cause. Both pathological ECD and TCD findings (ECD:
HR 3.46, 95% CI 1.56 to 7.66, P = 0.02; TCD: HR 4.97,
Table 2: Univariate analysis of variables possibly associated with new vascular events
Cerebral ischemic event Cardiovascular ischemic event Cerebral/cardiovascular ischemic event or vascular/
unknown death
HR 95% CI HR 95% CI HR 95% CI
Age 1.03 0.991.06 1.04 0.991.10 1.04 1.011.07
Sex, female 1.13 0.492.62 0.93 0.233.76 1.18 0.562.45
Hypertension 0.99 0.392.51 -* -* 1.20 0.542.68
Diabetes 2.11 0.835.35 5.00 1.4017.86 1.85 0.824.17
Hyperlipidemia 0.57 0.241.34 2.51 0.659.70 0.51 0.241.10
Body mass index > 30 0.30 0.042.24 1.06 0.215.26 0.52 0.151.76
Nicotine abuse 1.30 0.572.94 0.99 0.273.69 1.06 0.532.12
Atrial fibrillation 0.94 0.283.17 -* -* 1.02 0.352.93
Coronary artery disease 0.59 0.181.99 2.27 0.628.24 0.96 0.412.24
Cardiac failure 3.39 1.0011.55 2.77 0.3422.63 3.97 1.5110.45
Peripheral artery disease 7.64 2.9619.71 -* -* 7.42 3.2516.94
DWI abnormality 1.23 0.512.93 0.59 0.122.85 0.84 0.371.90
Duration 1.04 1.001.10 0.92 0.791.08 1.03 0.991.08
Duration ≥ 1 h and/or DWI 
abnormality
0.76 0.311.89 0.69 0.172.76 0.91 0.402.07
Vertebrobasilar TIA 0.17 0.021.24 1.33 0.325.46 0.39 0.121.30
ECD: stenoocclusion 4.39 1.939.99 3.73 1.0513.31 4.18 2.048.59
TCD: abnormal 4.99 1.9712.62 9.62 2.4637.68 5.13 2.2611.67
* Statistical analysis not possible due to small patient numbers.
SD: Standard deviation. HR: Hazard ratio. CI: Confidence interval.
Table 3: Predictors of new vascular events in multivariate analysis*
Cerebral ischemic event Cardiovascular ischemic event Cerebral/cardiovascular ischemic event or vascular/unknown 
death
HR 95% CI HR 95% CI HR 95% CI
ECD: stenoocclusion 4.30 1.7510.57 2.93 0.7711.17 3.46 1.567.66
TCD: abnormal 4.73 1.8612.04 18.51 3.4998.24 4.97 2.1611.47
* Cox proportional hazards multivariate analysis adjusted for age and sex.
HR: Hazard ratio. CI: Confidence interval.BMC Medical Imaging 2009, 9:13 http://www.biomedcentral.com/1471-2342/9/13
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95% CI 2.16 to 11.47, P < 0.001) proved to be predictors
of the combined endpoint in multivariate analysis (Table
3).
Discussion
The present study demonstrates that TIA patients with
ultrasonographic evidence of extracranial or intracranial
stenoocclusive disease are at high risk of further cerebral
ischemic events during medium- to long-term follow-up.
After a median follow-up of 27 months, nearly 40% of the
patients with either stenoocclusive disease in ECD or
pathological findings in TCD have suffered a new IS or
TIA. Several studies have already reported an increased
stroke incidence after TIA of large-artery atherosclerotic or
cardioembolic etiology as compared to other subtypes,
but to our knowledge only for short- and medium-term
follow-up [3,13-15]. Purroy et al., in this context, have
shown a 3-month stroke risk of 20% after TIA due to large-
artery atherosclerosis [14]. The present data demonstrate
that detection of stenoocclusive disease by ECD or TCD is
not only associated with a higher short-term stroke risk
after TIA but remains a predictor of recurrent cerebral
ischemia during medium- to long-term follow-up.
Whereas several previous studies found a significant asso-
ciation between prolonged symptom duration and recur-
rent cerebral ischemic events during short- and medium-
term follow-up after TIA [2,8-10,13], there was only a
trend that did not reach significance in this study. We also
could not show that TIA patients with acute ischemia on
DWI are at higher risk of further cerebral ischemic events
on medium- to long-term follow-up. Because of the lim-
ited number of patients, however, these findings may be
simply explained by chance.
As an additional result of the present study, vertebrobasi-
lar TIA allocation seems to be associated with a lower
recurrence rate of cerebral ischemia. This finding is con-
sistent with a recent systematic review of Flossmann et al.,
who noted a lower stroke incidence in patients with verte-
brobasilar TIA or minor stroke when data was confined to
hospital-based studies (OR 0.68, 95% CI 0.6 to 0.8), but
a higher stroke incidence when data was restricted to pop-
ulation-based studies (OR 1.48,95% CI 1.1 to 2.0) [33].
A second major finding of the present study is that detec-
tion of reactive collateral flow patterns or intracranial ste-
nosis by TCD predicts new cardiovascular ischemic events
on medium- to long-term follow-up after TIA. 5 of 18
(27.8%) patients with abnormal TCD findings, but only 4
of 134 (3%) patients without, have developed a subse-
quent cardiovascular ischemic event. The association
between TCD findings and cardiovascular prognosis is of
particular importance as cardiovascular disease becomes
the major cause of death on long-term follow-up after TIA
[22].
A high prevalence of asymptomatic CAD in patients with
cerebrovascular disease is well known [27]. Chimowitz et
al. documented abnormal cardiac stress tests in 50% of
TIA or stroke patients with large-artery occlusive disease
[34], with the rates being 25% in isolated intracranial
artery stenosis, 50% in isolated extracranial carotid steno-
sis, and even 83% in coexistent extracranial carotid and
intracranial artery stenosis [34]. In another study, sympto-
matic intracranial atherosclerosis was associated with a
52% risk of occult CAD [35]. However, whereas a strong
correlation between the extent of extracranial carotid and
coronary atherosclerosis is well accepted in Caucasians
[36], and guidelines already recommend coronary risk
evaluation in TIA patients based on the individual cardio-
vascular risk profile and the prevalence of carotid artery
disease [27], the relationship between intracranial athero-
sclerosis and CAD has not been sufficiently evaluated in
this ethnic group. In Asians, who suffer from intracranial
atherosclerosis more frequently than Caucasians, correla-
tion between extracranial carotid and coronary atheroscle-
rosis seems to be stronger than between intracranial artery
and coronary atherosclerosis [37].
Whereas pathological TCD findings proved to be a predic-
tor of new cardiovascular ischemic events in the present
study, detection of stenoocclusive disease by ECD failed
significance in multivariate analysis. However, as our def-
inition of stenoocclusive disease in ECD included both
cICA and cVA lesions, the results cannot be equated with
the prognostic value of isolated extracranial carotid dis-
ease, which might be higher. Moreover, the definition of
pathological TCD findings referred to both reactive collat-
eral blood flow secondary to extracranial lesions and
intracranial stenoocclusive disease in this study, thus
probably characterizing those TIA patients with the high-
est risk of generalized atherosclerosis and consequently
cardiovascular ischemic events. TCD is already accepted as
an accurate, safe, and cost-effective diagnostic tool for the
detection of intracranial stenoocclusive disease[38,39],
and is widely accessible in most countries. The results of
the present study support the routine use of TCD in addi-
tion to ECD in TIA patients. Moreover, routine screening
tests for CAD and aggressive prevention therapies should
be considered in TIA patients with pathological TCD find-
ings.
The present study has several limitations. A larger patient
cohort would have been necessary to improve the statisti-
cal power of the study and allow further subgroup analy-
ses. Moreover, follow-up was conducted as telephone or
mail interview only. Even though attending physicians
and/or hospitals were contacted to complete data, early
and minor vascular events may have been missed due to
limited ability of the patients to recall their symptoms
over the complete follow-up period. A further weakness of
the present study is the lack of angiographic validation ofBMC Medical Imaging 2009, 9:13 http://www.biomedcentral.com/1471-2342/9/13
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ECD and TCD findings. However, both ECD and TCD
have been shown to be accurate diagnostic tools for the
detection of extracranial and intracranial stenoocclusive
disease [38-40]. Finally, ECD and TCD classification did
not distinguish between symptomatic and asymptomatic
vessel disease in the present study.
Conclusion
The present study confirms the high risk of further cere-
bral ischemic events in TIA patients with ultrasonographic
evidence of extracranial or intracranial stenoocclusive dis-
ease during medium- to long-term follow-up. As patho-
logical TCD findings additionally predict new
cardiovascular ischemic events, routine screening tests for
CAD and aggressive prevention therapies should be con-
sidered in this subgroup of TIA patients. ECD and TCD are
important diagnostic procedures in patients with TIA.
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